Condensed Consolidated Statements Of Earnings (USD $) In Millions, except Per Share data	3 Months Ended
	Sep. 30, 2011		Sep. 30, 2010
Condensed Consolidated Statements Of Earnings
Revenue	$ 26,792.0		$ 24,437.5
Cost of products sold	25,707.5		23,475.3
Gross margin	1,084.5		962.2
Operating expenses:
Distribution, selling, general and administrative expenses	643.3		581.5
Restructuring and employee severance	3.4	[1]	1.8	[1]
Acquisition-related costs	27.4		11.7
Impairments and loss on sale of assets	1.3		1.9
Litigation (recoveries)/charges, net	(3.2)		1.4
Operating earnings	412.3		363.9
Other (income)/expense, net	3.8		(7.5)
Interest expense, net	23.5		22.0
Gain on sale of investment in CareFusion	0		(74.8)
Earnings before income taxes and discontinued operations	385.0		424.2
Provision for income taxes	147.9		129.8
Earnings from continuing operations	237.1		294.4
Earnings/(loss) from discontinued operations, net of tax	(0.3)		0.4
Net earnings	$ 236.8		$ 294.8
Basic earnings per Common Share:
Continuing operations	$ 0.69		$ 0.84
Discontinued operations	$ 0.00		$ 0.00
Net basic earnings per Common Share	$ 0.69		$ 0.84
Diluted earnings per Common Share:
Continuing operations	$ 0.68		$ 0.84
Discontinued operations	$ 0.00		$ 0.00
Net diluted earnings per Common Share	$ 0.68		$ 0.84
Weighted average number of Common Shares outstanding:
Basic	344.8		348.9
Diluted	349.4		351.9
Cash dividends declared per Common Share	$ 0.215		$ 0.195

[1] We incurred restructuring expenses related to the Spin-Off of $0.4 million and $0.9 million for the three months ended September 30, 2011 and 2010, respectively.